D-1241-2019 Class III Terminated
FDA drug recall D-1241-2019 was initiated by Akorn Inc on Apr 23, 2019 and is designated Class III. Reason for recall: Failed impurities/degradation specification: Out of Specification result for total impurity at 4.0% (Limit: NMT 3.0%) at 12 months stability testing. The recall status is terminated (terminated Jul 28, 2022). Affected quantity: 5,380 cartons (25 ampules per carton).
Recall details
- Product Type
- Drugs
- Report Date
- May 1, 2019
- Initiation Date
- Apr 23, 2019
- Termination Date
- Jul 28, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5,380 cartons (25 ampules per carton)
Product description
Fentanyl Citrate Injection, USP, 100 mcg/2 mL (50 mcg/mL), 25 Ampules per carton, (2 mL each), Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-030-25
Reason for recall
Failed impurities/degradation specification: Out of Specification result for total impurity at 4.0% (Limit: NMT 3.0%) at 12 months stability testing.
Distribution pattern
U.S.A. Nationwide
Code information
Lot #: 011198, Exp 01/22
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1241-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026